Use of A3 Subtype Adenosine-Receptor Antagonists to Treat Glaucoma
Description
Glaucoma affects an estimated three million people in the United States, with 300,000 new cases diagnosed every year. It is a major cause of human blindness and is usually associated with an elevation of pressure in the eye.